142 related articles for article (PubMed ID: 10473877)
1. The use of platelet glycoprotein IIb/IIIa receptor antagonists during the acute phase of myocardial infarction.
van den Brand M; Ronner EF
Semin Interv Cardiol; 1999 Jun; 4(2):85-8. PubMed ID: 10473877
[No Abstract] [Full Text] [Related]
2. [Glycoprotein IIb/IIIa receptor antagonists for improving thrombolytic and interventional therapy in patients with acute myocardial infarct].
Zeymer U; Neuhaus KL
Dtsch Med Wochenschr; 2000 Oct; 125(43):1297-300. PubMed ID: 11098229
[No Abstract] [Full Text] [Related]
3. Glycoprotein IIb/IIIa receptor antagonists: are we ignoring the evidence.
Singh S; Gopal AK; Bahl VK
Indian Heart J; 2005; 57(3):201-9. PubMed ID: 16196176
[No Abstract] [Full Text] [Related]
4. Platelet disaggregation: putting time on your side in acute myocardial infarction.
Simon DI; Sakuma M
J Am Coll Cardiol; 2004 Jul; 44(2):324-6. PubMed ID: 15261926
[No Abstract] [Full Text] [Related]
5. Overview of the use of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction.
Joseph A
J Emerg Med; 1999; 17(3):567-73. PubMed ID: 10338258
[No Abstract] [Full Text] [Related]
6. Is transport with platelet GP IIb/IIIa inhibition for primary percutaneous coronary intervention more efficient than on-site thrombolysis in patients with STEMI admitted to community hospitals? Randomised study. Early results.
Dobrzycki S; Mezyński G; Kralisz P; Prokopczuk P; Nowak K; Kochman W; Zuk J; Bachórzewska-Gajewska H; Sawicki Z; Poniatowski B; Korecki J; Musiał WJ
Kardiol Pol; 2006 Aug; 64(8):793-9; discussion 800-1. PubMed ID: 16981054
[TBL] [Abstract][Full Text] [Related]
7. IIb/IIIa inhibitors in acute myocardial infarction.
Montalescot G
Blood Coagul Fibrinolysis; 1999 Feb; 10 Suppl 1():S71-5. PubMed ID: 10070824
[TBL] [Abstract][Full Text] [Related]
8. The glycoprotein IIb/IIIa inhibitor wars: an update.
Berger PB
J Am Coll Cardiol; 2010 Aug; 56(6):476-8. PubMed ID: 20670757
[No Abstract] [Full Text] [Related]
9. [GPIIB/IIIA blockade after high-risk angioplasty: new perspectives].
Smiri Z; Lahidheb D; Hajlaoui N; Barakett N; Rahal N; Azzouzi F; Fehri W; Mhenni H; Haouala H
Tunis Med; 2003; 81 Suppl 8():617-24. PubMed ID: 14608749
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of platelet glycoprotein IIb/IIIa as augmenters of thrombolysis.
Eccleston D; Topol EJ
Coron Artery Dis; 1995 Dec; 6(12):947-55. PubMed ID: 8723017
[No Abstract] [Full Text] [Related]
11. Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: appropriate interpretation of the guidelines.
Antman EM
Am Heart J; 2003 Oct; 146(4 Suppl):S18-22. PubMed ID: 14564302
[TBL] [Abstract][Full Text] [Related]
12. Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable angina/non-ST-elevation myocardial infarction: a comparison of the Thrombolysis In Myocardial Infarction (TIMI) IIIB trial and the Treat angina with Aggrastat and determine Cost of Therapy with Invasive or Conservative Strategy (TACTICS)-TIMI 18 trial.
Sabatine MS; Morrow DA; Giugliano RP; Murphy SA; Demopoulos LA; DiBattiste PM; Weintraub WS; McCabe CH; Antman EM; Cannon CP; Braunwald E
Circulation; 2004 Feb; 109(7):874-80. PubMed ID: 14757697
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of glycoprotein IIb/IIIa inhibitors and clopidogrel alone and in combination in non-ST-segment elevation myocardial infarction (from the National Registry of Myocardial Infarction-4).
Bromberg-Marin G; Marin-Neto JA; Parsons LS; Canto JG; Rogers WJ;
Am J Cardiol; 2006 Nov; 98(9):1125-31. PubMed ID: 17056312
[TBL] [Abstract][Full Text] [Related]
14. The evolving role of glycoprotein IIb/IIIa inhibitor therapy in contemporary care of acute coronary syndrome patients.
Tricoci P; Peterson ED
J Interv Cardiol; 2006 Oct; 19(5):449-55. PubMed ID: 17020570
[TBL] [Abstract][Full Text] [Related]
15. Present and potential future paradigms for the treatment of ST-segment elevation acute myocardial infarction.
Chew DP; Moliterno DJ; Herrmann HC
J Invasive Cardiol; 2002 Feb; 14 Suppl A():3A-20A. PubMed ID: 11847402
[No Abstract] [Full Text] [Related]
16. [Blockers of platelet glycoprotein IIb/IIIa-receptors in the treatment of patients with acute coronary syndrome and during transcutaneous coronary interventions].
Fettser DV; Preobrazhenskiĭ DV; Batyraliev TA; Sidorenko BA; Aĭtach V
Ter Arkh; 2009; 81(1):84-7. PubMed ID: 19253720
[No Abstract] [Full Text] [Related]
17. New trials and therapies for acute myocardial infarction.
Gumina RJ
Med Clin North Am; 2007 Jul; 91(4):729-49; xii. PubMed ID: 17640545
[TBL] [Abstract][Full Text] [Related]
18. [Combination therapy for acute myocardial infarction with glycoprotein IIb/IIIa inhibitors and fibrinolysis].
Ottani F; Bresciani B; La Vecchia L; Favero L; Fontanelli A; Galvani M
Ital Heart J Suppl; 2002 May; 3(5):544-54. PubMed ID: 12064194
[TBL] [Abstract][Full Text] [Related]
19. Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative).
Alexander D; Mann N; Ou FS; Peterson ED; Ohman EM; Gibler WB; Roe MT
Am J Cardiol; 2008 Nov; 102(10):1335-40. PubMed ID: 18993151
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous integrin alphavbeta3 and glycoprotein IIb/IIIa inhibition causes reduction in infarct size in a model of acute coronary thrombosis and primary angioplasty.
Sakuma T; Sari I; Goodman CN; Lindner JR; Klibanov AL; Kaul S
Cardiovasc Res; 2005 Jun; 66(3):552-61. PubMed ID: 15914120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
